24 results
S-3ASR
BEAM
Beam Therapeutics Inc
27 Feb 24
Automatic shelf registration
6:10pm
and preclinical studies;
our ability to develop and maintain a sustainable portfolio of product candidates;
our ability to develop life-long … programs and preclinical studies;
our ability to develop and maintain a sustainable portfolio of product candidates;
our ability to develop life-long
8-K
EX-99.2
BEAM
Beam Therapeutics Inc
8 Jan 24
Results of Operations and Financial Condition
6:55am
updates on anticipated upcoming milestones.
“Our vision is to establish Beam as a sustainable, fully integrated company pioneering a new class … for sustainable long-term growth across multiple therapeutic areas.”
Pipeline Updates and 2024 Anticipated Milestones
Sickle Cell Disease (SCD) Franchise
Beam
424B5
BEAM
Beam Therapeutics Inc
10 May 23
Prospectus supplement for primary offering
5:10pm
or in early 2024, and for BEAM-302 in early 2024;
our ability to develop and maintain a sustainable portfolio of product candidates;
our ability
424B5
x8at4w5xc0w42qs1s
7 Jul 21
Prospectus supplement for primary offering
4:11pm
S-3ASR
mtcqzx2joolkxc
10 Jun 21
Automatic shelf registration
7:03am
10-Q
7l6 buqaa7uy
12 May 20
Quarterly report
4:14pm
10-K
gux7txibmrjt1gzm
30 Mar 20
Annual report
5:26pm
424B4
zalu3kiyiiut0aq8e
7 Feb 20
Prospectus supplement with pricing info
12:00am
S-1/A
wqeqio9be5abtwkvmqts
17 Jan 20
IPO registration (amended)
4:09pm
S-1
mmk5exzmhw
27 Sep 19
IPO registration
4:34pm